Keywords: skyepharma, shares, drop, fda, questions, flutiform, nda

SkyePharma shares drop 16% as FDA questions Flutiform NDA; could delay appro to 2nd-qtr 2008

Article | 13 August 2007

• Print This

Shares in London, UK-based drugmaker SkyePharma fell 16.3% to 18 pence on August 8, after it was told by the US Food and ...

Enjoying this article? To continue reading you need to login or subscribe.